University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Mitchel Berger, M.D.

Chair of Neurological Surgery
Neurosurgeon

Dr. Mitchel S. Berger, chair of Neurological Surgery, is a nationally recognized expert in treating brain and spinal cord tumors and tumor-related epilepsy in adults and children. He also is a specialist in brain mapping techniques, used to identify areas of motor, sensory and language function during surgery, and an expert in the use of the Gamma Knife for tumor treatment. He is co-director of the Adult Brain Tumor Surgery Program, director of the Brain Tumor Research Center and director of the Center for Neurological Injury and Repair.

Berger, a professor of neurosurgery at UCSF, earned a bachelor's degree from Harvard College in 1975 and a medical degree from the University of Miami School of Medicine in 1979. He completed an internship and residency at UCSF and was awarded a clinical fellowship in neuro-oncology by the American Cancer Society and a research fellowship with the Brain Tumor Research Center. He completed further fellowship training in neuro-oncology at UCSF and in pediatric neurosurgery at the Hospital for Sick Children of the University of Toronto, Canada. His professional activities include his election to the board of directors of the American Association of Neurological Surgeons and his appointment to the American Board of Neurological Surgeons. Berger is board certified in neurosurgery.

Read a Q&A with Berger.

Clinics

California Center for Pituitary Disorders
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (866) 559-5543

Fax: (415) 353-2889

Hours: Monday to Friday
8 a.m. – 5 p.m.

Neuro-Oncology Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2966
Fax: (415) 353-2167

Hours: Monday to Friday
8 a.m. – 5 p.m.

Neurosurgery Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-7500
Fax: (415) 353-2889

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

More about Mitchel Berger

Education

University of Miami School of Medicine 1979

Residencies

UCSF Medical Center, General Surgery 1979

Fellowships

UCSF Medical Center, Neuro-oncology 1985
Hospital for Sick Children, Toronto, Canada, Pediatric Neurological Surgery 1986

Selected Research and Publications

  1. Sandstrom RS, Foret MR, Grow DA, Haugen E, Rhodes CT, Cardona AE, Phelix CF, Wang Y, Berger MS, Lin CH. Epigenetic Regulation by Chromatin Activation Mark H3K4me3 in Primate Progenitor Cells within Adult Neurogenic Niche. Sci Rep. 2014; 4:5371.
  2. Hervey-Jumper SL, Berger MS. Role of surgical resection in low- and high-grade gliomas. Curr Treat Options Neurol. 2014 Apr; 16(4):284.
  3. Safaee M, Oh MC, Mummaneni PV, Weinstein PR, Ames CP, Chou D, Berger MS, Parsa AT, Gupta N. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults. J Neurosurg Pediatr. 2014 Apr; 13(4):393-9.
  4. Berger MS. Editorial: The fluorescein-guided technique. Neurosurg Focus. 2014 Feb; 36(2):E6.
  5. Berger MS. Editorial: Use of 5-aminolevulinic acid helps see the way beyond MRI. Neurosurg Focus. 2014 Feb; 36(2):E4.
  6. Safaee M, Sun MZ, Oh T, Aghi MK, Berger MS, McDermott MW, Parsa AT, Bloch O. Use of thrombin-based hemostatic matrix during meningioma resection: A potential risk factor for perioperative thromboembolic events. Clin Neurol Neurosurg. 2014 Apr; 119:116-20.
  7. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJ, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014 Jan 10; 343(6167):189-93.
  8. Bloch O, Crane CA, Fuks Y, Kaur R, Aghi MK, Berger MS, Butowski NA, Chang SM, Clarke JL, McDermott MW, Prados MD, Sloan AE, Bruce JN, Parsa AT. Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol. 2014 Jan; 16(2):274-9.
  9. Huse JT, Wallace M, Aldape KD, Berger MS, Bettegowda C, Brat DJ, Cahill DP, Cloughesy T, Haas-Kogan DA, Marra M, Miller CR, Nelson SJ, Salama SR, Soffietti R, Wen PY, Yip S, Yen K, Costello JF, Chang S. Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop. Neuro Oncol. 2014 Jan; 16(2):173-8.
  10. Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow AK, Phillips J, Smirnov I, Tom MW, Prados MD, James CD, Berger MS, Gupta N, Haas-Kogan DA. Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro Oncol. 2014 Mar; 16(3):352-60.
  11. Berger MS, Wachter RM, Greysen SR, Lau CY. Changing our culture to advance patient safety. J Neurosurg. 2013 Dec; 119(6):1359-69.
  12. Rolston JD, Han SJ, Lau CY, Berger MS, Parsa AT. Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg. 2014 Mar; 120(3):736-45.
  13. Berger M, Philips-Bute B, Guercio J, Hopkins TJ, James ML, Borel CO, Warner DS, McDonagh DL. A novel application for bolus remifentanil: blunting the hemodynamic response to Mayfield skull clamp placement. Curr Med Res Opin. 2014 Feb; 30(2):243-50.
  14. Han SJ, Saigal R, Rolston JD, Cheng JS, Lau CY, Mistry RI, McDermott MW, Berger MS. Targeted reduction in neurosurgical laboratory utilization: resident-led effort at a single academic institution. J Neurosurg. 2014 Jan; 120(1):173-7.
  15. Bucci M, Mandelli ML, Berman JI, Amirbekian B, Nguyen C, Berger MS, Henry RG. Quantifying diffusion MRI tractography of the corticospinal tract in brain tumors with deterministic and probabilistic methods. Neuroimage Clin. 2013; 3:361-8.
  16. Sun MZ, Kim JM, Oh MC, Safaee M, Kaur G, Clark AJ, Bloch O, Ivan ME, Kaur R, Oh T, Fouse SD, Phillips JJ, Berger MS, Parsa AT. Na?/K?-ATPase 2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro Oncol. 2013 Nov; 15(11):1518-31.
  17. Haskins WE, Zablotsky BL, Foret MR, Ihrie RA, Alvarez-Buylla A, Eisenman RN, Berger MS, Lin CH. Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme. Front Oncol. 2013; 3:182.
  18. Zusman EE, Heary RF, Stroink AR, Berger MS, Popp AJ, Friedlander RM, Martin NA, Lonser RR, Asthagiri AR. Philanthropy funding for neurosurgery research and program development. Neurosurgery. 2013 Jul; 73(1):177-83.
  19. Hiniker A, Lee HS, Chang S, Berger M, Perry A. Cortical ependymoma with unusual histologic features. Clin Neuropathol. 2013 Jul-Aug; 32(4):318-23.
  20. Jarzabek MA, Sweeney KJ, Evans RL, Jacobs AH, Stupp R, O'Brien D, Berger MS, Prehn JH, Byrne AT. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary. Drug Discov Today. 2013 Nov; 18(21-22):1052-66.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.